Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) EPS (Weighted Average and Diluted) (2016 - 2026)

Nutex Health (NUTX) has disclosed EPS (Weighted Average and Diluted) for 12 consecutive years, with $6.52 as the latest value for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 95.8% year-over-year to $6.52; the TTM value through Mar 2026 reached $12.94, up 2.21%, while the annual FY2025 figure was $10.48, 8.15% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $6.52 in Q1 2026 for Nutex Health, up from $1.61 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $11.12 in Q4 2024 and bottomed at -$7.47 in Q4 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.9, with a median of -$0.07 recorded in 2024.
  • Year-over-year, EPS (Weighted Average and Diluted) plummeted 37250.0% in 2023 and then soared 4262.5% in 2025.
  • Nutex Health's EPS (Weighted Average and Diluted) stood at -$0.02 in 2022, then tumbled by 37250.0% to -$7.47 in 2023, then soared by 248.86% to $11.12 in 2024, then plummeted by 85.52% to $1.61 in 2025, then surged by 304.97% to $6.52 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $6.52, $1.61, and $7.76 for Q1 2026, Q4 2025, and Q3 2025 respectively.